Register entry

Skyepharma Production SAS

Data as of · How to read this entry

Registered sites
1
Active NDC listings
4
Labeller names
2
Live patents
0
Countries
1
Base
France
Authorisation

Registered operations

Analytical testing1Labelling1Finished drug manufacture1Packaging1Relabelling1
Sites

Registered establishments

1
EstablishmentAddressRegistered forFEI / DUNS
SKYEPHARMA PRODUCTION SASRegistrant: Skyepharma Production SASZONE INDUSTRIELLE CHESNES OUEST 55 RUE DU MONTMURIER, ST QUENTIN FALLAVIER, 38070, France (FRA)Analytical testing, Labelling, Finished drug manufacture, Packaging, Relabelling3002808180383630456
Catalogue

Drug listings by form and route

4

4 active NDC listings: 4 drug for further processing. By marketing category: DRUG FOR FURTHER PROCESSING 4.

Dosage formNDCs
capsule4
RouteNDCs
Labeller name on the listingNDCs
skyepharma production sas2
skyepharma production sas2
Catalogue

Marketed products

4
BrandGeneric nameForm / routeNDC
-ZONISAMIDEcapsule13672-001DRUG FOR FURTHER PROCESSING
-ZONISAMIDEcapsule13672-002DRUG FOR FURTHER PROCESSING
-ZONISAMIDEcapsule13672-680DRUG FOR FURTHER PROCESSING
-ZONISAMIDEcapsule13672-681DRUG FOR FURTHER PROCESSING
Compare

Comparable companies in France

Enquiry

Common questions

Is Skyepharma Production SAS FDA approved?
Skyepharma Production SAS holds 1 FDA-registered establishment in France. Registration puts a site on the FDA's register and open to inspection; it is not an approval of the company. Approvals attach to individual drug applications.
Where are Skyepharma Production SAS's drugs manufactured?
The FDA register lists ST QUENTIN FALLAVIER. Registered operations: analytical testing, labelling, finished drug manufacture, packaging, relabelling.
What drugs does Skyepharma Production SAS make?
4 products are listed under Skyepharma Production SAS in the openFDA NDC Directory, most often as capsule. The full breakdown by dosage form and route is above. A listing count is not a sales figure.

Compiled from FDA establishment registrations, the openFDA NDC Directory, the Orange Book and the FDA drug shortage database. Not claimed by the company. Sources and methodology.